Skip to main content

Soraprazan - a new regenerative therapy for Stargardt's disease

Leistungen

Project Website

Public web-site launch of Soraprazan project to increase patients’ awareness

Veröffentlichungen

The STArgardt Remofuscin Treatment Trial (STARTT): design and baseline characteristics of enrolled Stargardt patients

Autoren: Patty P.A. Dhooge, Philipp T. Möller, Camiel J.F. Boon, Andrew J. Lotery, Philipp Herrmann, Maurizio Battaglia Parodi, Wolfgang Klein, Mario G. Fsadni, Thomas H. Wheeler-Schilling, Oliver Jungmann, Hans Müller, Frank G. Holz, Steffen Schmitz-Valckenberg, Tobias M. Peters, Katarina Stingl,15, Carel B. Hoyng, Soraprazan Consortium
Veröffentlicht in: Open Research Europe, 2021, ISSN 2732-5121
Herausgeber: European Commission
DOI: 10.12688/openreseurope.13872.1

Evaluation of Local Rod and Cone Function in Stargardt Disease

Autoren: Stingl, Krunoslav; Hoyng, Carel; Kempf, Melanie; Kohl, Susanne; Jung, Ronja; Righetti, Giulia; Kühlewein, Laura; Pohl, Lisa; Kortüm, Friederike; Kelbsch, Carina; Wilhelm, Barbara; Peters, Tobias; Stingl, Katarina; on behalf of the SORAPRAZAN consortium
Veröffentlicht in: Investigative ophthalmology & visual science, 63 (3), 2022, ISSN 0146-0404
Herausgeber: Association for Research in Vision and Ophthalmology
DOI: 10.1167/iovs.63.3.6